Streetbeat News

Stock Prices

KBH

KB Home (NYSE:KBH) is set to release its Q3 earnings, with expectations of $2.06 EPS and $1.73 billion in revenue. Analysts have revised their ratings and price targets, with mixed views ranging from Neutral to Underperform. The stock recently closed at $87.23, down 2.7%.

Portfolio Pulse from Avi Kapoor

September 23, 2024 | 7:44 am

SMTC

Semtech Corporation (NASDAQ:SMTC) is showcasing its new GN2255S Tri-Edge™ 50 Gbps CDR at ECOC 2024, targeting 5G and 6G networks. This innovation aims to enhance network performance and efficiency, crucial for future infrastructure upgrades driven by increasing data demands.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 7:42 am

AAPL

Apple Inc. (NASDAQ:AAPL) has discontinued several products, including the iPhone 15 Pro models and iPhone 13, as part of its annual product streamlining. This move comes amid mixed reports about the demand for the new iPhone 16, with some analysts predicting weak demand due to a lack of compelling features.

Portfolio Pulse from Ananya Gairola

September 23, 2024 | 7:26 am

EP

Empire Petroleum Corporation (NYSE:EP) announced a $10 million rights offering with a record date set for September 30, 2024. Shareholders will receive subscription rights to purchase additional shares at $5.05 each, with the offering expiring on October 16, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 7:15 am

MNDR

MaNaDr, a telehealth provider, received a Nasdaq notice for not meeting the minimum bid price rule, with a deadline until March 2025 to comply. The company must raise its share price above $1.00 for 10 consecutive days to avoid delisting.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 7:08 am

SABA

Saba Capital Income & Opportunities Fund II (NYSE:SABA) has announced a 10% share buyback plan to improve its net asset value (NAV) and reduce the discount to NAV. The buyback is set for the fiscal year ending October 31, 2025, and aims to enhance shareholder value.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 7:05 am

RKLB

Rocket Lab USA, Inc. (NASDAQ:RKLB) successfully launched its 53rd Electron mission, deploying five satellites for French IoT company Kinéis. This mission supports global IoT connectivity, marking another milestone for Rocket Lab in expanding its launch services.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 7:00 am

TEVA

Teva Pharmaceuticals announced positive Phase 3 trial results for TEV-749, a new long-acting injectable treatment for schizophrenia. The study showed significant improvements in key efficacy measures without the risk of post-injection delirium/sedation syndrome (PDSS), a common issue with current treatments. These findings were presented at the ECNP Congress, highlighting TEV-749's potential as a safer alternative for schizophrenia patients.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:57 am

IDYA

IDEAYA Biosciences is set to announce interim Phase 2 data for its drug darovasertib in treating uveal melanoma. The announcement will be made via a pre-market press release and an investor webcast on September 23, 2024. The webcast will cover clinical data, regulatory updates, and trial design.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:52 am

TEVA

Teva Pharmaceutical announced that a new analysis shows deutetrabenazine treatment leads to long-term improvement in Tardive Dyskinesia symptoms.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:44 am